Expectations for Reassessment with Next-Generation Obesity Drug Tech Transfer... How to Plan up to 4x Purchase Strategy
The technology transfer of next-generation obesity treatments by domestic pharmaceutical companies is emerging as a major factor for corporate value reassessment. Analysts suggest that since global partners, as latecomers to the obesity market, need to secure differentiated products, the development scope may expand to both monotherapies and combinations with existing treatments. Reflecting such potential and the prospects for subsequent technology transfers, brokerages have raised their target prices. However, the sales projections following product launches are estimates premised on successful development, approval, and commercialization.
If considering additional purchases, it is essential to distinguish between the maximum contract value and the actual inflow of contract payments and step-by-step development milestones. The total value of the technology transfer can include amounts contingent on meeting certain milestones, meaning the entire sum does not immediately translate into revenue or cash. Going forward, it will be important to assess how safety and the potential for muscle function improvement are demonstrated in early clinical trials and how the partner company's development plans are specified. It is necessary to evaluate the anticipated value and current performance separately, monitoring the results of subsequent clinical trials and cash inflows.
HISTOCKLOAN has maintained its position as the industry's number one for 22 years, operating a variety of stock financing products, including products boasting annual interest rates in the 5% range. It is attracting attention as an option for investors aiming to secure investment opportunities while easing their funding burden, as it can be used not only to secure new investment capital but also for fund management by refinancing margin and credit transactions.
[Go directly to the No.1 HISTOCKLOAN in the industry: https://www.hisl.co.kr]
Meanwhile, interest in stock secured loans (stockloans) is increasing day by day. More investors are turning to stockloans to leverage additional capital for share purchases, intent on not missing out on rare investment opportunities.
In addition, one of the advantages of stockloans is that even if a rapid drop in share prices triggers a forced sale crisis while using margin or credit, investors can simply switch to a new product without providing additional collateral or selling shares and then wait for a price rebound.
◆ HISTOCKLOAN: Additional investment funds as well as margin/credit refinancing at the industry’s lowest annual interest rate in the 5% range!
'HISTOCKLOAN' has launched a brokerage-linked credit product available to all investors at a low annual interest rate in the 5% range, allowing for a burden-free stockloan experience. It can be used for stock purchases as well as refinancing brokerage margin/credit, and can be leveraged up to four times the investor's own capital regardless of credit rating. Additionally, investors using the alternative trading system (NXT) can also utilize this product.
Investors interested in HISTOCKLOAN's wide range of tailored products can contact the customer consultation center (☎1566-5113) for convenient, 24/7 professional consultation, regardless of loan approval status.
○ New products launched with the industry's lowest annual interest rate in the 5% range
○ ETF trading available
○ Ranked No.1 in market share for 22 consecutive years, recipient of the Korea First Brand Award for 17 consecutive years
○ Immediate settlement of brokerage margin/credit
○ Alternative trading system (NXT) trading available
○ Reliable consultation with a quality assurance system
* HISTOCKLOAN Consultation Center: 1566-5113
Go directly: https://www.hisl.co.kr
Samsung Electro-Mechanics, Hanmi Pharm, Daewoo Engineering & Construction, Gaon Cable, SK hynix
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
※ The above content is unrelated to The Asia Business Daily’s editorial direction, and all liability rests with the information provider.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.